Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron before colorectal cancer surgery
ACTRN12618001437257Phase 4Terminated
- Sponsor
- Austin Health
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in iron deficiency anemia (IDA) comparing Ferric carboxymaltose with Placebo (2 arms). Primary endpoint: Change in peak oxygen uptake. Started Mar 2019; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12618001437257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001437257.